South Africa and India have pushed for a TRIPS waiver to temporarily allow states to produce Covid-19 technologies without fear of IP infringement. But it faces pressure from rich countries, who want to protect their pharmaceutical industries.
An estimated 26 million refugees and displaced people are at greater risk of contracting the illness region-wide, as they lack adequate access to water and hygiene services, the UN's Economic and Social Commission for Western Asia said.